Professor David Price
Chair of Primary Care Respiratory Med
- 51cg
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 5 of 20 Results 201 to 250 of 964
Clinical Remission in Oral Corticosteroid (OCS)-dependent Patients with Severe Asthma: An Analysis of the ANDHI-IP and PONENTE Trials
2023 ATS International Conference, C31Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Diagnostic Performance of a Machine Learning Algorithm (Asthma/Chronic Obstructive Pulmonary Disease [COPD] Differentiation Classification) Tool Versus Primary Care Physicians and Pulmonologists in Asthma, COPD, and Asthma/COPD Overlap
The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 5, pp. 1463-1474Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Data Resource Profile: United Kingdom Optimum Patient Care Research Database
Pragmatic and Observational Research, vol. 2023, no. 14, pp. 39-49Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Chronic Airways Assessment Test: Psychometric properties in patients with asthma and/or COPD
Respiratory Research, vol. 24, 106Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
IMPlementing IMProved Asthma self-management as RouTine (IMP2ART) in primary care: study protocol for a cluster randomised controlled implementation trial
Trials, vol. 24, 252Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Individualised risk prediction model for exacerbations in patients with severe asthma: Protocol for a multicentre real-world risk modelling study
BMJ Open, vol. 13, no. 3, e070459Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma
npj Primary Care Respiratory Medicine, vol. 33, no. 1, 9Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Ending the reign of short-acting β2-agonists in Australia?
TSANZSRS 2023, pp. 39Contributions to Journals: Abstracts- [ONLINE] DOI:
Demographic and Clinical Characteristics of Patients with Severe Asthma in the Asian Pacific Region: data from the International Severe Asthma Registry (ISAR)
APSR 2022, pp. 3-413Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Dupilumab sustains improvements in clinical efficacy and reductions in OCS use in patients with severe, OCS-dependent asthma: LIBERTY ASTHMA TRAVERSE study
APSR 2022, pp. 3-413Contributions to Journals: Abstracts- [ONLINE] DOI:
Ending the reign of short-acting β2-agonists in Australia?
APSR 2022, pp. 3-413Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
The association of short acting β2-agonist overuse with asthma control and severe exacerbations: an Australian perspective
APSR 2022, pp. 3-413Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Defining clinical subtypes of adult asthma using electronic health records: analysis of a large UK primary care database with external validation
International Journal of Medical Informatics, vol. 170, 104942Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Effect of stepping up to high-dose inhaled corticosteroids in patients with asthma: UK Database Study
The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 2, pp. 532-543Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Sustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
EAACI HYBRID CONGRESS 2022, pp. 237Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
An observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
ThoraxContributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Clinical recommendations for dry powder inhaler use in the management of COPD in primary care
npj Primary Care Respiratory Medicine, vol. 32, 59Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
Contributions to Conferences: Oral Presentations- [OPEN ACCESS]
Systemic Corticosteroids in Asthma: A Call to Action From World Allergy Organization and Respiratory Effectiveness Group
World Allergy Organization Journal, vol. 15, no. 12, 100726Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Adrenal function recovery after durable OCS-sparing with benralizumab in the PONENTE study
European Respiratory Journal, vol. 60, no. 6, 2103226Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma
European Respiratory Society (ERS) International Congress., 2814Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Burden of severe asthma by biologic use and eligibility: an analysis of the International Severe Asthma Registry
European Respiratory Society (ERS) International Congress., 2143Contributions to Journals: Abstracts- [ONLINE] DOI:
Carbon footprint of inhalers in respiratory treatment: SABA CARBON International
European Respiratory Society (ERS) International Congress., 2901Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Characterising the impact of sex on severe asthma (SA) in the UK Severe Asthma Registry (UKSAR)
European Respiratory Society (ERS) International Congress., 308Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
European Respiratory Society (ERS) International Congress., pp. 1552Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Mortality outcomes associated with oral corticosteroid use in patients with COPD
European Respiratory Society (ERS) International Congress., 1819Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Over-the-counter (OTC) short-acting β2-agonist (SABA) purchase and asthma outcomes in SABINA III
European Respiratory Society (ERS) International Congress., 3434Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Patient-reported barriers to accepting a technological adherence package in the MAGNIFY trial
European Respiratory Society (ERS) International Congress., 3402Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Persistent reductions in OCS use in patients with severe, OCS dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study
World Allergy Congress 2022, pp. 383Contributions to Journals: Abstracts- [ONLINE]
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
European Respiratory Society (ERS) International Congress., 3305Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Risk factors for corticosteroid- and antibiotic only-treated asthma attacks in the NOVELTY cohort
European Respiratory Society (ERS) International Congress., 2125Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
What have we learnt from real-life research in asthma and COPD?: Standards and novel designs for the future
Respirology, vol. 27, no. 12, pp. 1018-1021Contributions to Journals: Comments and Debates- [ONLINE] DOI:
Effectiveness of initiating biologics in severe asthma patients with high steroid exposure
European Respiratory Society (ERS) International Congress., 3405Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Proactive Risk Management: A Novel Approach to Embedding Oral Corticosteroid Stewardship into Asthma Care
European Medical Journal - Respiratory, vol. 10, no. Supplement 2Contributions to Journals: Articles- [ONLINE]
- [OPEN ACCESS]
Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study
British Thoracic Society Winter Meeting 2022, pp. A54Contributions to Conferences: Abstracts- [ONLINE]
- [ONLINE]
S88 Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study
Thorax, vol. 77, no. Suppl. 1, pp. A54Contributions to Journals: Abstracts- [ONLINE] DOI:
- [ONLINE]
P186 Facilitators to recruiting COPD patients to an adherence intervention trial
Thorax, vol. 77, no. Suppl. 1, A182Contributions to Journals: Abstracts- [ONLINE] DOI:
Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial
British Thoracic Society Winter Meeting 2022, pp. A72-A73Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [ONLINE]
Dupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthma
CHEST 2022, pp. A1909-A1913Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Characterization of patients in the International Severe Asthma Registry with high steroid exposure who did or did not initiate biologic therapy
Journal of Asthma and Allergy, vol. 15, no. 15, pp. 1491—1510Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
AMCP Nexus 2022Contributions to Conferences: AbstractsClinical outcomes in patients with severe asthma who had or had not initiated biologic therapy: results from the CLEAR study
CHEST 2022, pp. A28-A32Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Clinical Review: The suggested management pathway for urticaria in primary care
Clinical and Translational Allergy, vol. 12, no. 10, e12195Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy: results from the CLEAR study
CHEST Annual Meeting, pp. A23-A27Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Short-acting β2-agonist prescription patterns for asthma management in the SABINA III primary care cohort
npj Primary Care Respiratory Medicine, vol. 32, 37Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Suboptimal peak inspiratory flow and critical inhalation errors are associated with higher COPD-related healthcare costs
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2401-2415Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Oral corticosteroids in asthma and beyond: moving forward
European Respiratory Journal, vol. 60, no. 3, 2200776Contributions to Journals: Editorials- [ONLINE] DOI:
- [OPEN ACCESS]
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2187—2200Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Sociodemographic and clinical characteristics of patients with asthma who were prescribed ≥3 SABA canisters/year in the SABINA International study
European Respiratory Society (ERS) International Congress., pp. 2374Contributions to Conferences: Abstracts- [ONLINE]
- [OPEN ACCESS]
Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma
European Respiratory Society (ERS) International Congress., 4420Contributions to Journals: Abstracts- [ONLINE] DOI: